| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/26/2007 | US20070092497 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 04/26/2007 | US20070092490 High efficiency sin vector |
| 04/26/2007 | US20070092489 Use of receptor sequences for immobilizing gene vectors on surfaces |
| 04/26/2007 | US20070092484 MCP-1 splice variants and methods of using same |
| 04/26/2007 | DE102005049637A1 Antagonisten gegen die Interaktion von PF4 und RANTES Antagonists to the interaction of PF4 and RANTES |
| 04/26/2007 | CA2626067A1 Biologically excitable cells |
| 04/26/2007 | CA2625812A1 Reduction and prevention of cell-associated hiv transepithelial migration, microbides and other formulations and methods |
| 04/26/2007 | CA2625473A1 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics |
| 04/26/2007 | CA2624840A1 Carrier composition for nucleic acid transport |
| 04/26/2007 | CA2592065A1 Glp-1 agonists, compositions, methods and uses |
| 04/25/2007 | EP1776957A2 Use of herpes vectors for tumor therapy |
| 04/25/2007 | EP1776126A2 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 04/25/2007 | EP1320542B1 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 04/25/2007 | EP1259813B1 Diagnosis of malignant neoplasms |
| 04/25/2007 | EP1254174B1 Human cyr61 |
| 04/25/2007 | EP1253938B1 Immunization against carcinoma and the preliminary stages thereof |
| 04/25/2007 | EP1190056B1 Human cytokine receptor |
| 04/25/2007 | EP1054959B1 High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm |
| 04/25/2007 | EP0964925B1 A basal cell carcinoma tumor suppressor gene |
| 04/25/2007 | CN1952165A Use of pp3774 gene in inhibiting cell growth |
| 04/25/2007 | CN1952160A Recombinant of intelligent adenovirus vector and khp53 gene and application thereof |
| 04/25/2007 | CN1952146A Expression separation and purification method for Chinese Phytolacca acinosa cDNA mutant and TAT gene recombinant in prokaryon and application therefor |
| 04/25/2007 | CN1952135A Polynucleotide related to cell multiplication and its encoded polypeptide and application |
| 04/25/2007 | CN1952133A Polynucleotide activating ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952132A Polynucleotide having influence on ELK1 activity and its encoded polypeptide and application |
| 04/25/2007 | CN1952131A Neural protein NSPc1 having influence on nerve tumor cell differentiation by tretinoin signal pathway |
| 04/25/2007 | CN1952129A Angptl4缺失突变体及其应用 Angptl4 deletion mutant and its application |
| 04/25/2007 | CN1951961A Human Prox1 protein and its uses for resisting hepatitis B infection |
| 04/25/2007 | CN1951504A Zinc finger protein HZF1 gene function and application thereof |
| 04/25/2007 | CN1951503A Application of cytoskeleton like gene JWA in inhibiting toxicity of excitatory amino acid for treating Parkinson's diseases |
| 04/25/2007 | CN1951398A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 04/25/2007 | CN1312283C Smal linterference ribonucleic acid sequence of hepatitis B virus gene and preparing method |
| 04/25/2007 | CN1312175C Trichosanthin mutant and coding gene thereof |
| 04/25/2007 | CN1311871C DNA expression vectors and methods of use |
| 04/24/2007 | US7208655 A plant virus containing a predetermined foreign peptide as part of the coat protein of the virus |
| 04/24/2007 | US7208584 Fibroblast growth factor-13 |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208572 Modulation body weights; dietetics; eating disorders; polypeptide having specific amino acid sequence; amino acids is in the D-isoform |
| 04/24/2007 | US7208470 Treating testicular cancer, ovarian cancer, prostate cancer with a biodrug protein; activin binding activity; hormone inhibitor |
| 04/24/2007 | US7208466 Treating pain or inflammation; inhibiting C-fibre neuron activity; hemagglutinins conjugated with protein |
| 04/24/2007 | US7208315 Compositions and methods for efficient AAV vector production |
| 04/24/2007 | US7208314 Transfecting a cell by attaching a labile linkage to a polymeric membrane-active compound (polypeptide); adding the polymeric membrane-active compound to a solution containing the nucleic acid; and introducing to a cell; gene therapy |
| 04/24/2007 | US7208313 No virus replication in non-dividing cells |
| 04/24/2007 | US7208300 Enzymatic polypetide for use in the treatment of aneurysms and artheroslerosis |
| 04/24/2007 | US7208291 Protein comprising cytoplasmic domain, membrane-spanning domain and an extracellular domain with biotin-binding activity; avidin activity; endocytosis |
| 04/24/2007 | US7208283 Contacting with Ewing sarcoma protein and nuclear receptor; determining binding and changes in ligand-induced activity; use in diagnosis and treatment |
| 04/24/2007 | US7208280 Controlling gene expression in tissue |
| 04/24/2007 | US7208173 Mixed structures resulting from the incorporation of a biological macromolecule, especially of DNA, in a liquid crystal phase of amphiphiles, and vesicles obtained using these structures |
| 04/24/2007 | US7208153 Method for the improvement of neuronal regeneration |
| 04/24/2007 | CA2236482C Expression of cyclin g1 in tumors |
| 04/24/2007 | CA2220997C Adenovirus vectors for gene therapy |
| 04/24/2007 | CA2197793C New multimerizing agents |
| 04/24/2007 | CA2184345C Coordinate in vivo gene expression |
| 04/24/2007 | CA2136441C Adeno-associated virus with inverted terminal repeat sequences as promoter |
| 04/24/2007 | CA2091346C Methods and compositions for genetic therapy and potentiation of anti-tumor immunity |
| 04/19/2007 | WO2007044937A2 Compositions and methods to modulate memory |
| 04/19/2007 | WO2007044851A2 G-rich polynucleotides for the treatment of huntington's disease |
| 04/19/2007 | WO2007044627A2 Compositions and methods for delivery of interfering rna |
| 04/19/2007 | WO2007044468A2 Method to treat flavivirus infection with sirna |
| 04/19/2007 | WO2007044413A2 Wwox gene, vectors containing the same, and uses in treatment of cancer |
| 04/19/2007 | WO2007044396A2 Fibronectin polypeptides and methods of use |
| 04/19/2007 | WO2007044394A2 Compositions and methods for treatment of autoimmune disease |
| 04/19/2007 | WO2007044362A2 Allele-specific rna interference |
| 04/19/2007 | WO2007043784A1 Rna aptamers and the uses thereof |
| 04/19/2007 | WO2007043715A1 Rna-binding peptide |
| 04/19/2007 | WO2007043287A1 TRANSCRIPTIONAL REGULATION OF HIGH AFFINITY IgE RECEPTOR Ϝ-CHAIN |
| 04/19/2007 | WO2007041869A1 Reconstructed living adipose tissue |
| 04/19/2007 | WO2007001684A9 Inhibiting dna polymerase beta to enhance efficacy of anticancer agents |
| 04/19/2007 | WO2006116541A3 Tat-002 and methods of assessing and treating cancer |
| 04/19/2007 | WO2006078279A3 Sequential delivery of immunogenic molecules via adenovirus and adeno-associated virus-mediated administrations |
| 04/19/2007 | WO2006077112A3 Sirna molecules for treatment of blood vessels |
| 04/19/2007 | WO2006055697A3 Cancer immunotherapy incorporating p53 |
| 04/19/2007 | WO2005085458A3 Polyacetal-peptide mediated transfection |
| 04/19/2007 | WO2005056802A3 Materials and methods relating to cell cycle control |
| 04/19/2007 | WO2003002065A3 Hcv e1e2 vaccine compositions |
| 04/19/2007 | US20070089178 Modified Organs and Cells for Xenotransplantation |
| 04/19/2007 | US20070088155 siRNA targeting tumor necrosis factor superfamily member 1A |
| 04/19/2007 | US20070088154 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing |
| 04/19/2007 | US20070088153 siRNA targeting BCL2L1 |
| 04/19/2007 | US20070088152 siRNA targeting KRAS |
| 04/19/2007 | US20070087992 Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof |
| 04/19/2007 | US20070087991 Pluripotential stem cells |
| 04/19/2007 | US20070087989 siRNA specific for myocilin and mutant myocilin; double stranded RNA; gene expression inhibition; for treatment of glaucoma |
| 04/19/2007 | US20070087988 Hematopoietic progenitor kinase 1 for modulation of an immune response |
| 04/19/2007 | US20070087987 Modulation of glucagon receptor expression |
| 04/19/2007 | US20070087986 Compositions and methods for enhancing immunity by chemoattractant adjuvants |
| 04/19/2007 | US20070087985 MRCK-related compositions and methods |
| 04/19/2007 | US20070087984 Method of identifying agents that inhibit the growth of cancer cells |
| 04/19/2007 | US20070087983 Novel ubp8rp polypeptides and their use in the treatment of psoriasis |
| 04/19/2007 | US20070087982 Methods of treatment and diagnosis using modulators of virus-induced cellular gene sequences |
| 04/19/2007 | US20070087969 Wound healing and treatment of fibrosis |
| 04/19/2007 | US20070087967 Methods and compositions for inhibiting angiogenesis |
| 04/19/2007 | US20070087959 Method of inducing biomineralization method of inducing bone regeneration and methods related thereof |
| 04/19/2007 | US20070087433 Adeno-associated viral vector for use as heterologous gene transfer agent |
| 04/19/2007 | US20070087388 G protein coupled receptor |
| 04/19/2007 | US20070087363 Therapeutic methods, compounds and compositions |
| 04/19/2007 | US20070087349 Highly parallel template-based dna synthesizer |
| 04/19/2007 | US20070087045 Lipid carrier and method of preparing the same |
| 04/19/2007 | US20070087008 Rab9a, rab11a, and modulators thereof related to infectious disease |
| 04/19/2007 | US20070086989 Prosthetic Grafts |